Table of Contents
Clustered regular interspaced short palindromic repeats (CRISPR), specifically CRISPR-associated protein 9 (CRISPR-Cas9), represents a revolution in genetic engineering. For decades, genetic disorders have presented immense medical challenges, often with limited treatment options. CRISPR helps solve health problems that were once thought to be incurable.
Originating from a bacterial defense mechanism, CRISPR-Cas9 has been repurposed into an incredibly precise editor for DNA. This biological tool offers an unprecedented ability to modify genetic sequences with pinpoint accuracy, enabling the targeted adjustment of an organism’s fundamental genetic code.
As a result, teams can better understand and manipulate biological systems to improve human health outcomes. Danaher is driving this innovation.
How CRISPR gene therapy is progressing human health
Beyond inherited conditions, gene editing holds promise for addressing complex diseases, such as certain cancers, viral infections and neurological disorders, by precisely altering the genetic factors that contribute to their development.
CRISPR represents a shift in how we approach disease, moving from managing symptoms to addressing the root genetic causes. For instance, in cancer therapy, CRISPR can be used to engineer immune cells to specifically target and destroy cancer cells. This approach, known as CAR-T cell therapy, has shown remarkable success in treating certain blood cancers.
In the realm of viral infections, CRISPR is being explored as a means to directly target and disable viral DNA within infected cells, potentially offering a cure for chronic infections like HIV. Similarly, researchers are investigating CRISPR’s potential to correct genetic mutations that contribute to neurological disorders like Huntington’s disease and spinal muscular atrophy. These approaches often involve delivering the CRISPR-Cas9 system directly to the affected cells or tissues using viral vectors or lipid nanoparticles. The precision of CRISPR allows for targeted gene editing, minimizing off-target effects and maximizing therapeutic efficacy.
For those driven by a desire to contribute to monumental innovation and be at the forefront of redefining what’s possible in healthcare, the field of genetic innovation presents an outstanding opportunity. At Danaher, we’re not just observing this revolution — we’re actively enabling and accelerating CRISPR breakthroughs.
Danaher’s collaborative impact on CRISPR innovation
A cornerstone of our commitment to accelerating genetic innovation is our strategic partnership with the Innovative Genomics Institute (IGI), a leading scientific hub for CRISPR research founded by Jennifer Doudna, co-inventor of CRISPR. Together with the Chan Zuckerberg Initiative, Danaher proudly supports the Center for Pediatric CRISPR Cures. This collaboration is a testament to our shared vision of developing precise, on-demand genetic therapies for children facing severe genetic diseases.
This broader partnership is realized through the Danaher-IGI Beacon for CRISPR Cures. As the largest investment from Danaher’s Beacons program, this initiative is dedicated to enhancing academic research and establishing a transformative platform framework. Its core goal is to create a “CRISPR Cookbook.” This robust, clinically validated resource provides the following:
- Standardized protocols
- Essential reagents
- Guidelines for developing and scaling CRISPR cures
This groundbreaking work aims to address a family of rare immunological disorders, setting a precedent for future gene-editing therapies.
Our contribution extends beyond financial support. It involves providing the essential manufacturing infrastructure and contributing a wealth of tools, reagents, resources and expertise designed to simplify and expedite both preclinical and clinical development.
Powering gene editing
Bringing a novel genetic therapy into practice is a complex process. This is where Danaher’s operating companies, such as Integrated DNA Technologies (IDT) and Aldevron, shine.
IDT, a global leader in nucleic acid synthesis, played a crucial role in producing the high-quality guide RNA — the molecular map that directs the CRISPR machinery to the precise location in the genome.
Simultaneously, Aldevron, a premier manufacturer of plasmid DNA, mRNA and proteins, produced the mRNA gene editor and expertly packaged these components into lipid nanoparticles for safe and effective delivery to target cells.
Accelerating mRNA-CRISPR therapy breakthroughs
When an innovative mRNA-based personalized CRISPR therapy was developed for an individual facing a life-threatening condition, the Danaher Business System (DBS) proved indispensable. DBS, our proprietary operating system, is a set of proven tools and processes that drive continuous improvement, operational efficiency and innovation.
Through its application, a process that typically required 18-24 months was compressed into less than six months. This achievement was a testament to scientific ingenuity and our ability to coordinate complex, multi-faceted projects under extreme pressure, ensuring quality and speed at every step.
Empowering associates in genetic medicine
At Danaher, our associates are directly involved in building the very foundations of genetic medicine. We offer a unique environment where team members can work on cutting-edge projects and collaborate with leading scientific institutions like IGI and Stanford University.
Associates perform tasks that are shaping the future of medicine. It’s an opportunity for unparalleled personal and scientific growth — not to mention real global health impact.
Unique career paths driving CRISPR advancement at Danaher
The incredible advancements in CRISPR technology and genetic medicine require various talents and expertise. Danaher offers a landscape of career opportunities where individuals can directly contribute to the next generation of genetic breakthroughs.
Explore the variety of roles that support CRISPR innovation within our organization:
1. R&D Scientists and Engineers
These are the minds pushing the boundaries of scientific discovery. Our R&D teams are responsible for developing new CRISPR tools, optimizing gene-editing protocols, designing novel delivery systems for genetic therapies and exploring new applications for genomic technologies. From molecular to synthetic biologists and biochemical engineers, these roles involve hands-on experimentation, data analysis and the continuous pursuit of scientific excellence.
2. Software Engineers and Data Scientists
Our software engineers develop intuitive interfaces for instruments, build robust algorithms for genomic analysis, and create platforms to manage and interpret vast biological datasets. Data scientists use advanced analytics and machine learning to extract critical insights from large volumes of genetic information.
3. Manufacturing and Operations Specialists
Translating scientific breakthroughs into scalable, accessible therapies requires operational expertise. Professionals in manufacturing and operations are crucial for scaling the production of critical reagents, gene-editing components and therapeutic candidates. They optimize production workflows and implement good manufacturing practices to guarantee the safety and efficacy of products for research and clinical use.
4. Product Managers and Marketing Professionals
These roles bridge the gap between scientific innovation and market needs. Product managers define the strategy and roadmap for new CRISPR-enabling products, working closely with R&D, engineering and sales to bring solutions from concept to commercialization. Marketing professionals then educate the scientific community and ensure our groundbreaking tools reach the researchers and clinicians who need them most.
5. Field Application Scientists and Technical Support
Our solutions empower scientists worldwide. Field application scientists provide expert technical guidance, training and support to customers, helping them troubleshoot challenges and maximize the utility of Danaher’s CRISPR products. Technical support specialists help maintain our global operations.
This interdisciplinary environment is the foundation of Danaher’s approach. As an applicant, this means specific skills, whether rooted in science, engineering, operations or commercial strategy, can find a meaningful application at Danaher. We foster an environment of continuous learning, collaboration and opportunity, so team members can learn, adapt and make a tangible impact in this advancing field.
The real-world impact of Danaher’s CRISPR work
The ultimate measure of our success is the impact we have on human lives. Danaher’s contributions to CRISPR technology are direct investments in a future where diseases are overcome and quality of life is dramatically improved for individuals globally.
By providing the essential tools and infrastructure for gene editing, Danaher plays a deep role in translating scientific potential into tangible patient benefits.
Transforming genetic and immune disorders
For individuals suffering from genetic blood disorders like sickle cell disease and beta-thalassemia, gene editing offers the promise of a functional cure by correcting the underlying genetic mutations. These conditions, which can cause severe pain, organ damage and significantly reduced life expectancy, could be fundamentally altered and offer renewed hope for millions. CRISPR offers a potential pathway to restore immune function in individuals with inherited immune deficiencies.
Revolutionizing cancer treatment and disease research
Beyond inherited conditions, CRISPR is revolutionizing the approach to treating certain cancers. By engineering immune cells to more effectively recognize and eliminate cancer cells, gene editing is creating opportunities for personalized and highly effective oncology treatments.
The development of new diagnostics, enabled by the precision of CRISPR, also means earlier and more accurate disease detection. Our tools support the creation of advanced disease models, allowing researchers to study complex conditions, like neurological disorders, with unprecedented accuracy.
Ensuring responsible innovation
Danaher is deeply committed to supporting not just the development of these therapies, but also their responsible and ethical application.
Our focus is on providing robust, reliable and standardized tools so researchers and clinicians can pursue safe, effective applications of CRISPR. We emphasize rigorous quality control and best practices in manufacturing and application.
Joining Danaher means aligning with a powerful mission — to improve human health worldwide. It means contributing to solutions that directly empower researchers to develop treatments for devastating diseases. The DBS offers opportunities to be part of truly world-changing efforts that create a healthier, more hopeful future for humanity.
Choose a career at the forefront of innovation
For those passionate about science, technology and making a tangible impact on global health, Danaher offers a dynamic environment where potential is recognized and celebrated. We believe that our success is directly linked to the success and development of our associates. Danaher is committed to fostering a culture that helps our team members thrive.
Drive progress
At the core of Danaher is a culture of continuous improvement and innovation. We’re relentless in our pursuit of breakthrough ideas and solutions, always challenging the status quo and embracing new technologies. Associates are constantly engaged in meaningful work that pushes the boundaries of scientific knowledge and technological capability.
At Danaher, we encourage curiosity, foster an environment where different viewpoints are valued and empower teams to collaborate and solve complex problems.
Accelerate career potential
We recognize that talent is our greatest asset. We’re deeply invested in our global team’s growth. Danaher offers extensive opportunities for continuous learning, professional development programs, and clear pathways for career advancement within a portfolio of leading science and technology companies.
Whether an applicant aspires to deepen their technical expertise, transition into leadership or explore new functional areas, we provide the resources and mentorship to help our employees achieve their career goals. Our global reach means team members can explore various roles and opportunities across different operating companies and geographies, expanding their horizons and building a truly impactful career.
Join us in shaping the future of health
Our commitment to scientific excellence is matched by our dedication to creating a workplace where integrity and respect are priorities. You’ll be part of a team that’s passionate about its work, driven by a shared mission to improve human health.
At Danaher, we believe in fostering a collaborative environment where different perspectives are valued, and every team member has the opportunity to contribute their unique talents to solve some of the world’s most pressing health challenges. We actively promote a culture of inclusion and belonging, where all employees feel empowered to bring their whole selves to work.
Joining Danaher means working at the forefront of science and technology every day. It means contributing to solutions that transform lives and shape the future of medicine.
If you’re an ambitious, driven individual who wants to make a real difference, Danaher is where your contributions are valued, your potential is nurtured and your work truly matters. Learn more about Danaher today, and explore our life sciences careers to get started.